Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI116891

Reduced beta 1 receptor messenger RNA abundance in the failing human heart.

M R Bristow, W A Minobe, M V Raynolds, J D Port, R Rasmussen, P E Ray, and A M Feldman

Temple Hoyne Buell Laboratories, Division of Cardiology, University of Colorado Health Sciences Center, Denver 80262.

Find articles by Bristow, M. in: JCI | PubMed | Google Scholar

Temple Hoyne Buell Laboratories, Division of Cardiology, University of Colorado Health Sciences Center, Denver 80262.

Find articles by Minobe, W. in: JCI | PubMed | Google Scholar

Temple Hoyne Buell Laboratories, Division of Cardiology, University of Colorado Health Sciences Center, Denver 80262.

Find articles by Raynolds, M. in: JCI | PubMed | Google Scholar

Temple Hoyne Buell Laboratories, Division of Cardiology, University of Colorado Health Sciences Center, Denver 80262.

Find articles by Port, J. in: JCI | PubMed | Google Scholar

Temple Hoyne Buell Laboratories, Division of Cardiology, University of Colorado Health Sciences Center, Denver 80262.

Find articles by Rasmussen, R. in: JCI | PubMed | Google Scholar

Temple Hoyne Buell Laboratories, Division of Cardiology, University of Colorado Health Sciences Center, Denver 80262.

Find articles by Ray, P. in: JCI | PubMed | Google Scholar

Temple Hoyne Buell Laboratories, Division of Cardiology, University of Colorado Health Sciences Center, Denver 80262.

Find articles by Feldman, A. in: JCI | PubMed | Google Scholar

Published December 1, 1993 - More info

Published in Volume 92, Issue 6 on December 1, 1993
J Clin Invest. 1993;92(6):2737–2745. https://doi.org/10.1172/JCI116891.
© 1993 The American Society for Clinical Investigation
Published December 1, 1993 - Version history
View PDF
Abstract

Heart failure in humans is characterized by alterations in myocardial adrenergic signal transduction, the most prominent of which is down-regulation of beta 1-adrenergic receptors. We tested the hypothesis that down-regulation of beta 1-adrenergic receptors in the failing human heart is related to decreased steady-state levels of beta 1 receptor mRNA. Due to the extremely low abundance of beta 1 receptor mRNA, measurements were possible only by quantitative polymerase chain reaction (QPCR) or by RNase protection methods. Because the beta 1 receptor gene is intronless and beta 1 receptor mRNA abundance is low, QPCR yielded genomic amplification in total RNA, and mRNA measurements had to be performed in poly (A)(+)-enriched RNA. By QPCR the concentration of beta 1 receptor mRNA varied from 0.34 to 7.8 x 10(7) molecules/microgram poly(A)(+)-enriched RNA, and the assay was sensitive to 16.7 zeptomol. Using 100-mg aliquots of left ventricular myocardium obtained from organ donors (nonfailing ventricles, n = 12) or heart transplant recipients (failing ventricles, n = 13), the respective beta 1 mRNA levels measured by QPCR were 4.2 +/- 0.7 x 10(7)/micrograms vs. 2.10 +/- 0.3 x 10(7)/micrograms (P = 0.006). In these same nonfailing and failing left ventricles the respective beta 1-adrenergic receptor densities were 67.9 +/- 6.9 fmol/mg vs. 29.6 +/- 3.5 fmol/mg (P = 0.0001). Decreased mRNA abundance in the failing ventricles was confirmed by RNase protection assays in total RNA, which also demonstrated a 50% reduction in beta 1 message abundance. We conclude that down-regulation of beta 1 receptor mRNA contributes to down-regulation of beta 1 adrenergic receptors in the failing human heart.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2737
page 2737
icon of scanned page 2738
page 2738
icon of scanned page 2739
page 2739
icon of scanned page 2740
page 2740
icon of scanned page 2741
page 2741
icon of scanned page 2742
page 2742
icon of scanned page 2743
page 2743
icon of scanned page 2744
page 2744
icon of scanned page 2745
page 2745
Version history
  • Version 1 (December 1, 1993): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts